PDB Short entry for 5J31 HEADER SIGNALING PROTEIN 30-MAR-16 5J31 TITLE CRYSTAL STRUCTURE OF 14-3-3ZETA IN COMPLEX WITH AN ALKYNE CROSS-LINKED TITLE 2 CYCLIC PEPTIDE DERIVED FROM EXOS COMPND MOL_ID: 1; COMPND 2 MOLECULE: 14-3-3 PROTEIN ZETA/DELTA; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: PROTEIN KINASE C INHIBITOR PROTEIN 1,KCIP-1; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: EXOENZYME S; COMPND 8 CHAIN: C, D; COMPND 9 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YWHAZ; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: ROSETTA; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PPROEX HTB; SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 ORGANISM_SCIENTIFIC: PSEUDOMONAS AERUGINOSA; SOURCE 14 ORGANISM_TAXID: 287 KEYWDS CONSTRAINED PEPTIDES, PROTEIN-PROTEIN-INTERACTION, ALKYNE CROSS-LINK, KEYWDS 2 14-3-3 PROTEIN ZETA, SIGNALING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR K.WALLRAVEN,P.CROMM,D.BIER,A.GLAS,T.GROSSMANN REVDAT 3 10-JAN-24 5J31 1 LINK REVDAT 2 26-OCT-16 5J31 1 JRNL REVDAT 1 19-OCT-16 5J31 0 JRNL AUTH P.M.CROMM,K.WALLRAVEN,A.GLAS,D.BIER,A.FURSTNER,C.OTTMANN, JRNL AUTH 2 T.N.GROSSMANN JRNL TITL CONSTRAINING AN IRREGULAR PEPTIDE SECONDARY STRUCTURE JRNL TITL 2 THROUGH RING-CLOSING ALKYNE METATHESIS. JRNL REF CHEMBIOCHEM V. 17 1915 2016 JRNL REFN ESSN 1439-7633 JRNL PMID 27596722 JRNL DOI 10.1002/CBIC.201600362 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 2.5.1 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 47.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 38425 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.166 REMARK 3 R VALUE (WORKING SET) : 0.163 REMARK 3 FREE R VALUE : 0.219 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 2025 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3826 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 9 REMARK 3 SOLVENT ATOMS : 358 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 62.86 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 65.54 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 6.09000 REMARK 3 B22 (A**2) : -2.03000 REMARK 3 B33 (A**2) : -4.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.175 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.176 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.129 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 5.801 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS U VALUES : REFINED INDIVIDUALLY REMARK 4 REMARK 4 5J31 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 06-APR-16. REMARK 100 THE DEPOSITION ID IS D_1000219865. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-MAY-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS 2015 REMARK 200 DATA SCALING SOFTWARE : XSCALE 2015 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 40511 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 47.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.28 REMARK 200 R MERGE (I) : 0.05300 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 29.5400 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.60 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 13.79 REMARK 200 R MERGE FOR SHELL (I) : 0.50800 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 5.880 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER 2.5.1 REMARK 200 STARTING MODEL: 4FJ3 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 73.74 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.68 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.26 M TRI-SODIUM CITRATE, 0.09 M REMARK 280 HEPES PH 7.5, 10% GLYCEROL, VAPOR DIFFUSION, SITTING DROP, REMARK 280 TEMPERATURE 277.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 41.97000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 57.25500 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.79000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 57.25500 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 41.97000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.79000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4850 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 23320 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -19.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 207 REMARK 465 SER B 207 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE2 GLU B 209 O HOH B 401 1.39 REMARK 500 CB SER A 230 O HOH A 301 1.85 REMARK 500 OG SER A 230 O HOH A 301 1.86 REMARK 500 O ALA A 109 O HOH A 302 1.99 REMARK 500 O THR A 229 O HOH A 303 2.01 REMARK 500 OG SER B 210 O HOH B 402 2.01 REMARK 500 O HOH A 401 O HOH A 436 2.01 REMARK 500 O HOH B 474 O HOH B 528 2.05 REMARK 500 CE MET A 1 O HOH A 447 2.08 REMARK 500 OH TYR A 211 O HOH A 304 2.09 REMARK 500 CD2 LEU B 206 O HOH B 549 2.09 REMARK 500 O HOH A 311 O HOH A 317 2.14 REMARK 500 O GLU B 208 CE1 TYR B 211 2.15 REMARK 500 O HOH B 413 O HOH B 420 2.16 REMARK 500 O HOH B 515 O HOH B 561 2.17 REMARK 500 O HOH A 421 O HOH A 465 2.18 REMARK 500 OE1 GLU B 209 O HOH B 403 2.19 REMARK 500 O HOH B 425 O HOH B 476 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH A 450 O HOH B 528 4555 2.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ALA B 134 CB - CA - C ANGL. DEV. = 14.2 DEGREES REMARK 500 GLY B 135 N - CA - C ANGL. DEV. = -20.7 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 18 79.34 -112.00 REMARK 500 ARG B 18 73.56 -111.81 REMARK 500 PHE B 104 -57.55 -124.74 REMARK 500 ASN B 183 73.36 36.75 REMARK 500 SER B 184 61.04 -152.33 REMARK 500 SER B 210 88.88 -162.89 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ALA B 134 GLY B 135 -36.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 469 DISTANCE = 6.53 ANGSTROMS REMARK 525 HOH A 470 DISTANCE = 6.99 ANGSTROMS REMARK 525 HOH B 568 DISTANCE = 6.77 ANGSTROMS REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue BEZ B 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ASP C 424 and ZS8 C REMARK 800 425 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ZS8 C 425 and LEU C REMARK 800 426 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ASP D 424 and ZS8 D REMARK 800 425 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for Di-peptide ZS8 D 425 and LEU D REMARK 800 426 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 4N7G RELATED DB: PDB REMARK 900 RELATED ID: 4N7Y RELATED DB: PDB REMARK 900 RELATED ID: 4N84 RELATED DB: PDB DBREF 5J31 A 1 230 UNP P63104 1433Z_HUMAN 1 230 DBREF 5J31 B 1 230 UNP P63104 1433Z_HUMAN 1 230 DBREF 5J31 C 421 430 UNP Q93SQ3 Q93SQ3_PSEAI 421 430 DBREF 5J31 D 421 430 UNP Q93SQ3 Q93SQ3_PSEAI 421 430 SEQADV 5J31 ZS8 C 425 UNP Q93SQ3 ALA 425 ENGINEERED MUTATION SEQADV 5J31 ZS8 D 425 UNP Q93SQ3 ALA 425 ENGINEERED MUTATION SEQRES 1 A 230 MET ASP LYS ASN GLU LEU VAL GLN LYS ALA LYS LEU ALA SEQRES 2 A 230 GLU GLN ALA GLU ARG TYR ASP ASP MET ALA ALA CYS MET SEQRES 3 A 230 LYS SER VAL THR GLU GLN GLY ALA GLU LEU SER ASN GLU SEQRES 4 A 230 GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL SEQRES 5 A 230 GLY ALA ARG ARG SER SER TRP ARG VAL VAL SER SER ILE SEQRES 6 A 230 GLU GLN LYS THR GLU GLY ALA GLU LYS LYS GLN GLN MET SEQRES 7 A 230 ALA ARG GLU TYR ARG GLU LYS ILE GLU THR GLU LEU ARG SEQRES 8 A 230 ASP ILE CYS ASN ASP VAL LEU SER LEU LEU GLU LYS PHE SEQRES 9 A 230 LEU ILE PRO ASN ALA SER GLN ALA GLU SER LYS VAL PHE SEQRES 10 A 230 TYR LEU LYS MET LYS GLY ASP TYR TYR ARG TYR LEU ALA SEQRES 11 A 230 GLU VAL ALA ALA GLY ASP ASP LYS LYS GLY ILE VAL ASP SEQRES 12 A 230 GLN SER GLN GLN ALA TYR GLN GLU ALA PHE GLU ILE SER SEQRES 13 A 230 LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY SEQRES 14 A 230 LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU SEQRES 15 A 230 ASN SER PRO GLU LYS ALA CYS SER LEU ALA LYS THR ALA SEQRES 16 A 230 PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU SER GLU SEQRES 17 A 230 GLU SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU SEQRES 18 A 230 ARG ASP ASN LEU THR LEU TRP THR SER SEQRES 1 B 230 MET ASP LYS ASN GLU LEU VAL GLN LYS ALA LYS LEU ALA SEQRES 2 B 230 GLU GLN ALA GLU ARG TYR ASP ASP MET ALA ALA CYS MET SEQRES 3 B 230 LYS SER VAL THR GLU GLN GLY ALA GLU LEU SER ASN GLU SEQRES 4 B 230 GLU ARG ASN LEU LEU SER VAL ALA TYR LYS ASN VAL VAL SEQRES 5 B 230 GLY ALA ARG ARG SER SER TRP ARG VAL VAL SER SER ILE SEQRES 6 B 230 GLU GLN LYS THR GLU GLY ALA GLU LYS LYS GLN GLN MET SEQRES 7 B 230 ALA ARG GLU TYR ARG GLU LYS ILE GLU THR GLU LEU ARG SEQRES 8 B 230 ASP ILE CYS ASN ASP VAL LEU SER LEU LEU GLU LYS PHE SEQRES 9 B 230 LEU ILE PRO ASN ALA SER GLN ALA GLU SER LYS VAL PHE SEQRES 10 B 230 TYR LEU LYS MET LYS GLY ASP TYR TYR ARG TYR LEU ALA SEQRES 11 B 230 GLU VAL ALA ALA GLY ASP ASP LYS LYS GLY ILE VAL ASP SEQRES 12 B 230 GLN SER GLN GLN ALA TYR GLN GLU ALA PHE GLU ILE SER SEQRES 13 B 230 LYS LYS GLU MET GLN PRO THR HIS PRO ILE ARG LEU GLY SEQRES 14 B 230 LEU ALA LEU ASN PHE SER VAL PHE TYR TYR GLU ILE LEU SEQRES 15 B 230 ASN SER PRO GLU LYS ALA CYS SER LEU ALA LYS THR ALA SEQRES 16 B 230 PHE ASP GLU ALA ILE ALA GLU LEU ASP THR LEU SER GLU SEQRES 17 B 230 GLU SER TYR LYS ASP SER THR LEU ILE MET GLN LEU LEU SEQRES 18 B 230 ARG ASP ASN LEU THR LEU TRP THR SER SEQRES 1 C 10 GLY MK8 LEU ASP ZS8 LEU ASP LEU ALA SER SEQRES 1 D 10 GLY MK8 LEU ASP ZS8 LEU ASP LEU ALA SER MODRES 5J31 MK8 C 422 LEU MODIFIED RESIDUE MODRES 5J31 MK8 D 422 LEU MODIFIED RESIDUE HET MK8 C 422 9 HET ZS8 C 425 13 HET MK8 D 422 9 HET ZS8 D 425 13 HET BEZ B 301 9 HETNAM MK8 2-METHYL-L-NORLEUCINE HETNAM ZS8 (2S)-2-AMINO-2-METHYLDEC-8-YNOIC ACID HETNAM BEZ BENZOIC ACID FORMUL 3 MK8 2(C7 H15 N O2) FORMUL 3 ZS8 2(C11 H19 N O2) FORMUL 5 BEZ C7 H6 O2 FORMUL 6 HOH *358(H2 O) HELIX 1 AA1 ASP A 2 ALA A 16 1 15 HELIX 2 AA2 ARG A 18 GLU A 31 1 14 HELIX 3 AA3 SER A 37 THR A 69 1 33 HELIX 4 AA4 ALA A 72 PHE A 104 1 33 HELIX 5 AA5 PHE A 104 ALA A 109 1 6 HELIX 6 AA6 GLN A 111 VAL A 132 1 22 HELIX 7 AA7 ALA A 133 GLY A 135 5 3 HELIX 8 AA8 ASP A 136 MET A 160 1 25 HELIX 9 AA9 HIS A 164 LEU A 182 1 19 HELIX 10 AB1 SER A 184 LEU A 206 1 23 HELIX 11 AB2 SER A 210 SER A 230 1 21 HELIX 12 AB3 ASP B 2 ALA B 16 1 15 HELIX 13 AB4 ARG B 18 GLN B 32 1 15 HELIX 14 AB5 SER B 37 THR B 69 1 33 HELIX 15 AB6 ALA B 72 PHE B 104 1 33 HELIX 16 AB7 GLN B 111 GLU B 131 1 21 HELIX 17 AB8 ASP B 137 MET B 160 1 24 HELIX 18 AB9 HIS B 164 ILE B 181 1 18 HELIX 19 AC1 SER B 184 LEU B 206 1 23 HELIX 20 AC2 SER B 210 SER B 230 1 21 LINK C GLY C 421 N MK8 C 422 1555 1555 1.26 LINK C MK8 C 422 N LEU C 423 1555 1555 1.38 LINK CE MK8 C 422 CK1 ZS8 C 425 1555 1555 1.50 LINK C ASP C 424 N ZS8 C 425 1555 1555 1.34 LINK C ZS8 C 425 N LEU C 426 1555 1555 1.27 LINK C GLY D 421 N MK8 D 422 1555 1555 1.21 LINK C MK8 D 422 N LEU D 423 1555 1555 1.37 LINK CE MK8 D 422 CK1 ZS8 D 425 1555 1555 1.48 LINK C ASP D 424 N ZS8 D 425 1555 1555 1.38 LINK C ZS8 D 425 N LEU D 426 1555 1555 1.29 CISPEP 1 GLU B 208 GLU B 209 0 -0.02 SITE 1 AC1 3 ARG A 222 GLN B 219 ARG B 222 SITE 1 AC2 9 ARG A 41 ASN A 42 SER A 45 LYS A 49 SITE 2 AC2 9 GLY C 421 MK8 C 422 LEU C 423 LEU C 426 SITE 3 AC2 9 ASP C 427 SITE 1 AC3 10 ARG A 41 ASN A 42 SER A 45 LYS A 120 SITE 2 AC3 10 PRO A 165 MK8 C 422 LEU C 423 ASP C 424 SITE 3 AC3 10 ASP C 427 LEU C 428 SITE 1 AC4 12 ARG B 41 ASN B 42 LYS B 49 PHE B 117 SITE 2 AC4 12 GLY D 421 MK8 D 422 LEU D 423 LEU D 426 SITE 3 AC4 12 ASP D 427 HOH D 501 HOH D 504 HOH D 506 SITE 1 AC5 9 ARG B 41 ASN B 42 PHE B 117 LYS B 120 SITE 2 AC5 9 MK8 D 422 LEU D 423 ASP D 424 ASP D 427 SITE 3 AC5 9 LEU D 428 CRYST1 83.940 105.580 114.510 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011913 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009471 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008733 0.00000